QPPV.COM KNOWLEDGE ASSESSMENT

Zanubrutinib: Discovery, Development, Safety and Pharmacovigilance — Knowledge Assessment

Test your understanding of the concepts covered by Zanubrutinib: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Early development found high BTK occupancy in peripheral blood across studied doses, while sustained high occupancy in lymph-node biopsies was more frequent with 160 mg twice daily than with 320 mg once daily. What is the most appropriate interpretation?
Question 2 of 10 Why should response rate, progression-free survival, overall survival and adverse-event discontinuation not be treated as interchangeable trial outcomes?
Question 3 of 10 A patient with pre-existing severe hepatic impairment and a patient with suspected new drug-induced liver injury require which distinct considerations?
Question 4 of 10 A reviewer is considering extrapolating efficacy results from one zanubrutinib-treated B-cell malignancy to another. What is the most appropriate principle?
Question 5 of 10 What can the early single-arm MCL studies most directly support, and what can they not directly establish?
Question 6 of 10 A patient is changing from capsules to tablets. Which counselling point best reflects the presentation-specific instructions described in the article?
Question 7 of 10 The 2026 PRAC discussion recommended adding nausea information to EU product information and requested future cumulative reviews of syncope and acute kidney injury. Which interpretation is most accurate?
Question 8 of 10 A label reports a percentage of serious infections in a pooled clinical-trial population. How should a PV professional describe that figure?
Question 9 of 10 A second primary malignancy is diagnosed after prolonged zanubrutinib exposure. Which interpretation best reflects the article's pharmacovigilance approach?
Question 10 of 10 A safety team observes a cluster of spontaneous reports for an event. Which conclusion is most appropriate before further evaluation?

Select an answer to continue.

QPPV.com